Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery.
暂无分享,去创建一个
Hong Zhang | Yang Luo | D. Xiang | Guiyin Sun | Chu-rong Wu | K. Ding | Xiaohui Chen | Xiaohui Wang | Debing Xiang
[1] W. Zhang,et al. AIPH-Encapsulated Thermo-Sensitive Liposomes for Synergistic Microwave Ablation and Oxygen-independent Dynamic Therapy. , 2023, Advanced healthcare materials.
[2] Yang Luo,et al. Intelligent Dual-Lock Deoxyribonucleic Acid Automatons Boosting Precise Tumor Imaging. , 2023, ACS applied materials & interfaces.
[3] R. Pei,et al. Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetration. , 2022, Journal of materials chemistry. B.
[4] Zhao Ma,et al. Transformable nanoparticles to bypass biological barriers in cancer treatment , 2022, Nanoscale advances.
[5] E. Nice,et al. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies , 2022, Journal of Hematology & Oncology.
[6] Kinam Park,et al. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. , 2022, Advanced drug delivery reviews.
[7] Xuanrong Sun,et al. Legumain/pH dual-responsive lytic peptide–paclitaxel conjugate for synergistic cancer therapy , 2022, Drug delivery.
[8] E. Gazit,et al. Ultrasound-Responsive Peptide Nanogels to Balance Conflicting Requirements for Deep Tumor Penetration and Prolonged Blood Circulation. , 2022, ACS nano.
[9] Wei Huang,et al. Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines , 2022, Advanced science.
[10] S. Mitragotri,et al. Strategies to improve the EPR effect: A mechanistic perspective and clinical translation. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[11] Sheng Lin,et al. Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer , 2022, Drug delivery.
[12] G. Wang,et al. Transferrin Protein Corona-Modified CuGd Core-Shell Nanoplatform for Tumor-Targeting Photothermal and Chemodynamic Synergistic Therapies. , 2022, ACS applied materials & interfaces.
[13] S. Horrigan,et al. Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo , 2022, Cancers.
[14] Yueqing Gu,et al. A cascade synergetic strategy induced by photothermal effect based on platelet exosome nanoparticles for tumor therapy. , 2022, Biomaterials.
[15] Yihui Deng,et al. PEGylated nanoemulsions containing 1,2-distearoyl-sn-glycero-3-phosphoglycerol induced weakened accelerated blood clearance phenomenon , 2021, Drug Delivery and Translational Research.
[16] Wei Wang,et al. A nano-catalyst promoting endogenous NO production enhance chemotherapy efficacy by vascular normalization , 2022, Materials Chemistry Frontiers.
[17] Wing‐Leung Wong,et al. Review of Functionalized Nanomaterials for Photothermal Therapy of Cancers , 2021, ACS Applied Nano Materials.
[18] D. Berry,et al. Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial , 2021, Nature Communications.
[19] Xuebin Ma,et al. Effect of Elasticity of Silica Capsules on Cellular Uptake. , 2021, Langmuir : the ACS journal of surfaces and colloids.
[20] Xuan Yi,et al. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. , 2021, Nanoscale.
[21] Yiye Li,et al. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy. , 2021, ACS nano.
[22] Ruibing Wang,et al. Polyamine-Responsive Morphological Transformation of a Supramolecular Peptide for Specific Drug Accumulation and Retention in Cancer Cells. , 2021, Small.
[23] Xuesi Chen,et al. Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy. , 2021, Nano letters.
[24] T. Ishida,et al. Evidence for Delivery of Abraxane via a Denatured-Albumin Transport System. , 2021, ACS applied materials & interfaces.
[25] J. Tuszynski,et al. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. , 2021, Molecular pharmaceutics.
[26] Assaf Zinger,et al. Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles , 2021, ACS nano.
[27] Yaping Li,et al. Tumor-permeated bioinspired theranostic nanovehicle remodels tumor immunosuppression for cancer therapy. , 2020, Biomaterials.
[28] K. Lam,et al. Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart Nanomaterials. , 2020, ACS nano.
[29] Liang Yan,et al. Progress, challenges, and future of nanomedicine , 2020 .
[30] Xiaodi Zhang,et al. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib , 2020, Drug design, development and therapy.
[31] P. Lan,et al. Engineered exosome for NIR-triggered drug delivery and superior synergistic chemo-phototherapy in a glioma model , 2020 .
[32] S. Wilhelm,et al. Nanoparticle Toxicology. , 2020, Annual review of pharmacology and toxicology.
[33] Yan-Hua Su,et al. MicroRNA-101 inhibits cadmium-induced angiogenesis by targeting cyclooxygenase-2 in primary human umbilical vein endothelial cells. , 2020, Biochemical pharmacology.
[34] Weiling Fu,et al. Spatiotemporally Controllable MicroRNA Imaging in Living Cells via NIR-activated Nanoprobe. , 2020, ACS applied materials & interfaces.
[35] Yong Gan,et al. MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy , 2020, Advanced science.
[36] W. Zhong,et al. Gold Nanoparticles Induce Tumor Vessel Normalization and Impair Metastasis by Inhibiting Endothelial Smad2/3 Signaling. , 2020, ACS nano.
[37] Challenging paradigms in tumour drug delivery , 2020, Nature Materials.
[38] S. Nie,et al. Active transcytosis and new opportunities for cancer nanomedicine , 2020, Nature Materials.
[39] Hanchun Yao,et al. Mild Acid Responsive "Nanoenzyme Capsule" Remodeling of Tumor Microenvironment to Increase Tumor Penetration. , 2020, ACS applied materials & interfaces.
[40] T. Higashi,et al. Efficient Anticancer Drug Delivery for Pancreatic Cancer Treatment Utilizing Supramolecular Polyethylene-Glycosylated Bromelain. , 2020, ACS applied bio materials.
[41] Man Li,et al. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[42] P. Liang,et al. Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy , 2020, Frontiers in Pharmacology.
[43] J. Moodera,et al. One compound with two distinct topological states , 2020, Nature Materials.
[44] D. Zhao,et al. Size and charge dual-transformable mesoporous nanoassemblies for enhanced drug delivery and tumor penetration† , 2020, Chemical science.
[45] Yuancheng Li,et al. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles , 2020, Theranostics.
[46] Hao Wang,et al. Photothermal-Promoted Morphology Transformation in Vivo Monitored by Photoacoustic Imaging. , 2020, Nano letters.
[47] S. Wilhelm,et al. The entry of nanoparticles into solid tumours , 2020, Nature Materials.
[48] Shibo Wang,et al. Remodeling extracellular matrix based on functional covalent organic framework to enhance tumor photodynamic therapy. , 2020, Biomaterials.
[49] Yury E. Glazyrin,et al. Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer , 2020, Cancers.
[50] Stefanie Wedepohl,et al. Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model , 2020, Theranostics.
[51] Yaping Li,et al. Long Circulation Red‐Blood‐Cell‐Mimetic Nanoparticles with Peptide‐Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer , 2016, Advanced Functional Materials.
[52] Yu Zhang,et al. Engineered nanomedicines with enhanced tumor penetration , 2019 .
[53] A. Chiang,et al. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies , 2019, Nature Nanotechnology.
[54] Jin-Zhi Du,et al. Intratumor Performance and Therapeutic Efficacy of PAMAM Dendrimers Carried by Clustered Nanoparticles. , 2019, Nano letters.
[55] Arun Prasath,et al. Nanoparticles' interactions with vasculature in diseases. , 2019, Chemical Society reviews.
[56] Peng Xu,et al. Size effect of mesoporous organosilica nanoparticles on tumor penetration and accumulation. , 2019, Biomaterials science.
[57] Z. Qian,et al. Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment. , 2019, Nano letters.
[58] Zhuang Liu,et al. Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy , 2019, Science Advances.
[59] Xing-Jie Liang,et al. Thermo-responsive triple-function nanotransporter for efficient chemo-photothermal therapy of multidrug-resistant bacterial infection , 2019, Nature Communications.
[60] Tingting Meng,et al. Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells , 2019, Theranostics.
[61] T. Dvir,et al. Collagenase Nanoparticles Enhance the Penetration of Drugs Into Pancreatic Tumors. , 2019, ACS nano.
[62] Hélder A Santos,et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy , 2019, Nature Communications.
[63] Jing Wang,et al. Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles , 2019, Nature Communications.
[64] Huajian Gao,et al. Role of Nanoparticle Mechanical Properties in Cancer Drug Delivery. , 2019, ACS nano.
[65] Zhihua Gan,et al. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy , 2019, Nature Nanotechnology.
[66] Jeffrey W. Clark,et al. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. , 2019, JAMA oncology.
[67] Yong Wang,et al. Shape Effect of Nanoparticles on Tumor Penetration in Monolayers Versus Spheroids. , 2019, Molecular pharmaceutics.
[68] Jun Xu,et al. Hyaluronidase with pH‐responsive Dextran Modification as an Adjuvant Nanomedicine for Enhanced Photodynamic‐Immunotherapy of Cancer , 2019, Advanced Functional Materials.
[69] Yapei Zhang,et al. Near-Infrared-Light Induced Nanoparticles with Enhanced Tumor Tissue Penetration and Intelligent Drug Release , 2019, Acta biomaterialia.
[70] Jie Tian,et al. Microwave Responsive Nanoplatform via P-Selectin Mediated Drug Delivery for Treatment of Hepatocellular Carcinoma with Distant Metastasis. , 2019, Nano letters.
[71] Samir Mitragotri,et al. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. , 2019, Advanced drug delivery reviews.
[72] M. I. Setyawati,et al. Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness , 2019, Nature Nanotechnology.
[73] Jiajun Fu,et al. Acid and light stimuli-responsive mesoporous silica nanoparticles for controlled release , 2019, Journal of Materials Science.
[74] Z. Meng,et al. Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated? , 2018, Integrative cancer therapies.
[75] X. Yang,et al. Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem , 2018, Nature Communications.
[76] Di Zhang,et al. Nanopurpurin-based photodynamic therapy destructs extracellular matrix against intractable tumor metastasis. , 2018, Biomaterials.
[77] Ding Ding,et al. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.
[78] Ling Li,et al. Efficiency against multidrug resistance by co-delivery of doxorubicin and curcumin with a legumain-sensitive nanocarrier , 2018, Nano Research.
[79] Jinzhao Huang,et al. Synergizing Upconversion Nanophotosensitizers with Hyperbaric Oxygen to Remodel the Extracellular Matrix for Enhanced Photodynamic Cancer Therapy. , 2018, ACS applied materials & interfaces.
[80] Xinghua Shi,et al. Targeting Endothelial Cell Junctions with Negatively Charged Gold Nanoparticles , 2018 .
[81] Huan Meng,et al. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer. , 2018, Advanced drug delivery reviews.
[82] Triantafyllos Stylianopoulos,et al. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.
[83] Bo Zhang,et al. Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer , 2018, Journal of drug targeting.
[84] Jianhua Zhang,et al. Modulating the rigidity of nanoparticles for tumor penetration. , 2018, Chemical communications.
[85] A. Middelberg,et al. Understanding the Effects of Nanocapsular Mechanical Property on Passive and Active Tumor Targeting. , 2018, ACS nano.
[86] Chen Jiang,et al. Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy , 2018, Advanced science.
[87] Gang Zheng,et al. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. , 2018, Biomaterials.
[88] Youyong Yuan,et al. Ultrafast charge-conversional nanocarrier for tumor-acidity-activated targeted drug elivery. , 2018, Biomaterials science.
[89] P. Decuzzi,et al. Modulating Phagocytic Cell Sequestration by Tailoring Nanoconstruct Softness. , 2018, ACS nano.
[90] Ronnie H. Fang,et al. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis. , 2017, ACS nano.
[91] Dongdong Li,et al. Photoswitchable Ultrafast Transactivator of Transcription (TAT) Targeting Effect for Nanocarrier‐Based On‐Demand Drug Delivery , 2018 .
[92] Dong Hwee Kim,et al. Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy , 2018 .
[93] M. Moses,et al. Nanoparticle elasticity directs tumor uptake , 2018, Nature Communications.
[94] Qixian Chen,et al. Tumor-Targeted Accumulation of Ligand-Installed Polymeric Micelles Influenced by Surface PEGylation Crowdedness. , 2017, ACS applied materials & interfaces.
[95] Yu Sakurai,et al. Nano‐sized drug carriers: Extravasation, intratumoral distribution, and their modeling , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[96] Pengcheng Zhang,et al. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer. , 2017, Biomaterials.
[97] Ick Chan Kwon,et al. Extracellular matrix remodeling in vivo for enhancing tumor‐targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[98] C. Moonen,et al. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. , 2017, Advanced drug delivery reviews.
[99] T. Ji,et al. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy. , 2017, ACS nano.
[100] K. Cai,et al. Design of nanocarriers based on complex biological barriers in vivo for tumor therapy , 2017 .
[101] Yaping Li,et al. Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors. , 2017, Nano letters.
[102] Xian‐Zheng Zhang,et al. Stimuli-Responsive "Cluster Bomb" for Programmed Tumor Therapy. , 2017, ACS nano.
[103] Yifat Brill-Karniely,et al. Rigidity of polymer micelles affects interactions with tumor cells , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[104] Bruno Larrivée,et al. Tumor angiogenesis and vascular normalization: alternative therapeutic targets , 2017, Angiogenesis.
[105] Jianjun Cheng,et al. Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors , 2017, Advanced materials.
[106] David R. Myers,et al. Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions , 2017, Nature Communications.
[107] Ting-Wei Yu,et al. Hierarchically Targeted and Penetrated Delivery of Drugs to Tumors by Size‐Changeable Graphene Quantum Dot Nanoaircrafts for Photolytic Therapy , 2017 .
[108] Miles A. Miller,et al. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts , 2017, Science Translational Medicine.
[109] Leaf Huang,et al. Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. , 2017, ACS nano.
[110] Chor Yong Tay,et al. Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. , 2017, ACS nano.
[111] Youqing Shen,et al. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization , 2017, Advanced materials.
[112] Mahdi Karimi,et al. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light. , 2017, Journal of the American Chemical Society.
[113] Xiyi Chen,et al. Controlled PEGylation Crowdedness for Polymeric Micelles To Pursue Ligand-Specified Privileges as Nucleic Acid Delivery Vehicles. , 2017, ACS applied materials & interfaces.
[114] K. Bensalah,et al. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. , 2017, European urology.
[115] D. Xing,et al. Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy. , 2017, Biomaterials.
[116] M. I. Setyawati,et al. Mesoporous Silica Nanoparticles as an Antitumoral-Angiogenesis Strategy. , 2017, ACS applied materials & interfaces.
[117] E. Ruoslahti. Tumor penetrating peptides for improved drug delivery , 2017, Advanced drug delivery reviews.
[118] K. Kogure,et al. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization. , 2017, Biomacromolecules.
[119] I. Correia,et al. The effect of the shape of gold core-mesoporous silica shell nanoparticles on the cellular behavior and tumor spheroid penetration. , 2016, Journal of materials chemistry. B.
[120] Ligeng Xu,et al. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.
[121] S. Shen,et al. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer. , 2016, Biomaterials.
[122] Huile Gao. Shaping Tumor Microenvironment for Improving Nanoparticle Delivery. , 2016, Current drug metabolism.
[123] Flavio Rizzolio,et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. , 2016, Nanomedicine.
[124] Haijun Yu,et al. Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer. , 2016, ACS nano.
[125] I. Park,et al. Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features , 2016, Cancer Chemotherapy and Pharmacology.
[126] Jun Wang,et al. Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration. , 2016, ACS nano.
[127] Shaoyi Jiang,et al. Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response , 2016 .
[128] M. Maskos,et al. Tuning the Surface of Nanoparticles: Impact of Poly(2-ethyl-2-oxazoline) on Protein Adsorption in Serum and Cellular Uptake. , 2016, Macromolecular bioscience.
[129] Joseph W. Nichols,et al. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. , 2016, Nature nanotechnology.
[130] E. Rankin,et al. Hypoxia: Signaling the Metastatic Cascade. , 2016, Trends in cancer.
[131] Quanyin Hu,et al. ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging , 2016, Theranostics.
[132] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[133] I. Tohnai,et al. Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles , 2016, Scientific Reports.
[134] Hao Cheng,et al. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. , 2016, Nano letters.
[135] Liangzhu Feng,et al. Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy. , 2016, Nano letters.
[136] Jun Wang,et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.
[137] Yuliang Zhao,et al. Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation , 2015, Angewandte Chemie.
[138] K. Ghaghada,et al. Crossing the barrier: treatment of brain tumors using nanochain particles. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[139] Yuan Yuan,et al. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). , 2016, Acta biomaterialia.
[140] Shuai Shao,et al. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. , 2016, Biomaterials.
[141] Qian Liu,et al. Ultraviolet light-mediated drug delivery: Principles, applications, and challenges. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[142] Leaf Huang,et al. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[143] William Y. Kim,et al. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[144] Xing Guo,et al. Size Changeable Nanocarriers with Nuclear Targeting for Effectively Overcoming Multidrug Resistance in Cancer Therapy , 2015, Advanced materials.
[145] Huile Gao,et al. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment , 2015, Oncotarget.
[146] Ying Li,et al. Shape effect in cellular uptake of PEGylated nanoparticles: comparison between sphere, rod, cube and disk. , 2015, Nanoscale.
[147] S. Sreenivasan,et al. Effect of Shape, Size, and Aspect Ratio on Nanoparticle Penetration and Distribution inside Solid Tissues Using 3D Spheroid Models , 2015, Advanced healthcare materials.
[148] Min Feng,et al. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[149] Xing-jie Liang,et al. A Peptide‐Network Weaved Nanoplatform with Tumor Microenvironment Responsiveness and Deep Tissue Penetration Capability for Cancer Therapy , 2015, Advanced materials.
[150] I. Tannock,et al. The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[151] Yijia Zhang,et al. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. , 2015, Biomaterials.
[152] B. Groner,et al. Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma. , 2015, Cancer research.
[153] Gang Bao,et al. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. , 2015, Nanoscale.
[154] Jianbin Tang,et al. The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.
[155] R. Haag,et al. Dendritic nanocarriers based on hyperbranched polymers. , 2015, Chemical Society reviews.
[156] Huile Gao,et al. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. , 2015, Nanoscale.
[157] J. Kopeček,et al. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer. , 2015, Journal of the American Chemical Society.
[158] Siling Wang,et al. pH‐ and NIR Light‐Responsive Micelles with Hyperthermia‐Triggered Tumor Penetration and Cytoplasm Drug Release to Reverse Doxorubicin Resistance in Breast Cancer , 2015 .
[159] M. Ferrari,et al. Mild Hyperthermia Enhances Transport of Liposomal Gemcitabine and Improves In Vivo Therapeutic Response , 2015, Advanced healthcare materials.
[160] Jennifer S. Yu,et al. Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling. , 2015, Cancer research.
[161] Erkki Ruoslahti,et al. Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain , 2015, Journal of Molecular Medicine.
[162] J. Willmann,et al. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[163] H. Kuh,et al. Improving drug delivery to solid tumors: priming the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[164] Baoquan Ding,et al. Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake , 2015, Advanced materials.
[165] Qiang Zhang,et al. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma , 2015, Drug delivery.
[166] E. Puré,et al. Nanoparticles Functionalized with Collagenase Exhibit Improved Tumor Accumulation in a Murine Xenograft Model , 2014, Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems.
[167] Youqing Shen,et al. Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs , 2014, Advanced materials.
[168] R. Jain,et al. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.
[169] Andrew L. Ferguson,et al. Investigating the optimal size of anticancer nanomedicine , 2014, Proceedings of the National Academy of Sciences.
[170] Felix Kratz,et al. A clinical update of using albumin as a drug vehicle - a commentary. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[171] G. Wahl,et al. Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.
[172] Brandon S. Brown,et al. Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.
[173] Mark E. Davis,et al. Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA , 2014, Proceedings of the National Academy of Sciences.
[174] Triantafyllos Stylianopoulos,et al. The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.
[175] Wayne Kreider,et al. Passive cavitation detection during pulsed HIFU exposures of ex vivo tissues and in vivo mouse pancreatic tumors. , 2014, Ultrasound in medicine & biology.
[176] Q. Ping,et al. Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration. , 2014, Angewandte Chemie.
[177] J. Hinchion,et al. Releasing pressure in tumors: what do we know so far and where do we go from here? A review. , 2014, Cancer research.
[178] Xiaoyuan Chen,et al. Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles , 2014, ACS nano.
[179] Xin Cai,et al. Radioactive 198Au-Doped Nanostructures with Different Shapes for In Vivo Analyses of Their Biodistribution, Tumor Uptake, and Intratumoral Distribution , 2014, ACS nano.
[180] P. Decuzzi,et al. Heat-generating iron oxide nanocubes: subtle "destructurators" of the tumoral microenvironment. , 2014, ACS nano.
[181] Samir Mitragotri,et al. Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. , 2014, Nano today.
[182] S. Šelemetjev,et al. Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration , 2014, Croatian medical journal.
[183] Baran D. Sumer,et al. A Broad Nanoparticle-Based Strategy for Tumor Imaging by Nonlinear Amplification of Microenvironment Signals , 2013, Nature materials.
[184] Aniruddha Roy,et al. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[185] K. Rice,et al. PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expression. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[186] Takahiro Nomoto,et al. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. , 2013, ACS nano.
[187] Quanyin Hu,et al. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. , 2013, Biomaterials.
[188] H. Taguchi,et al. Biomolecular robotics for chemomechanically driven guest delivery fuelled by intracellular ATP. , 2013, Nature chemistry.
[189] Xian Xu,et al. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. , 2013, Molecular pharmaceutics.
[190] M. Yokoyama,et al. Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenon. , 2013, Biological & pharmaceutical bulletin.
[191] Yaping Li,et al. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.
[192] Dai Fukumura,et al. Vascular normalization as an emerging strategy to enhance cancer immunotherapy. , 2013, Cancer research.
[193] Say Chye Joachim Loo,et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin , 2013, Nature Communications.
[194] X. Liu,et al. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery. , 2013, Biomaterials.
[195] Min Wu,et al. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. , 2013, Journal of theoretical biology.
[196] Hyung J. Kim,et al. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. , 2013, ACS nano.
[197] Derek S. Chan,et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.
[198] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[199] James E Bear,et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. , 2012, Nano letters.
[200] Erkki Ruoslahti,et al. Transtumoral targeting enabled by a novel neuropilin-binding peptide , 2012, Oncogene.
[201] Alexander A. Fingerle,et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.
[202] Samir Mitragotri,et al. Materials for Drug Delivery: Innovative Solutions to Address Complex Biological Hurdles , 2012, Advanced materials.
[203] F. Kiessling,et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[204] I. Elkin,et al. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. , 2012, Current medicinal chemistry.
[205] E. Rofstad,et al. High Interstitial Fluid Pressure Is Associated with Tumor-Line Specific Vascular Abnormalities in Human Melanoma Xenografts , 2012, PloS one.
[206] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[207] A. Ray,et al. Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. , 2012, Nano today.
[208] T. Golub,et al. Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion , 2012, Nature.
[209] Robert Langer,et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.
[210] R. Jain,et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.
[211] R. Langer,et al. Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery , 2012, Journal of the American Chemical Society.
[212] Y. Maitani,et al. Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. , 2012, International journal of pharmaceutics.
[213] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[214] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[215] Jin-Zhi Du,et al. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.
[216] S. Dangi‐Garimella,et al. MT1-MMP Cooperates with KrasG12D to Promote Pancreatic Fibrosis through Increased TGF-β Signaling , 2011, Molecular Cancer Research.
[217] Mary E Napier,et al. More effective nanomedicines through particle design. , 2011, Small.
[218] Lei Xu,et al. Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.
[219] Jesse V Jokerst,et al. Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.
[220] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[221] J. Au,et al. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures. , 2011, Molecular pharmaceutics.
[222] Y. Anraku,et al. Size-controlled long-circulating PICsome as a ruler to measure critical cut-off disposition size into normal and tumor tissues. , 2011, Chemical communications.
[223] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[224] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[225] P. Wust,et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.
[226] Dai Fukumura,et al. A nanoparticle size series for in vivo fluorescence imaging. , 2010, Angewandte Chemie.
[227] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[228] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[229] Jin-Zhi Du,et al. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. , 2010, Angewandte Chemie.
[230] Ick Chan Kwon,et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[231] A. Giannis,et al. Cyclopamine and hedgehog signaling: chemistry, biology, medical perspectives. , 2010, Angewandte Chemie.
[232] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[233] Dong Chen,et al. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.
[234] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[235] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[236] Victor Frenkel,et al. Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle. , 2009, Ultrasound in medicine & biology.
[237] I. Pastan,et al. Pulsed High-Intensity Focused Ultrasound Enhances Uptake of Radiolabeled Monoclonal Antibody to Human Epidermoid Tumor in Nude Mice , 2008, Journal of Nuclear Medicine.
[238] J. Au,et al. Tumor Priming Enhances Delivery and Efficacy of Nanomedicines , 2007, Journal of Pharmacology and Experimental Therapeutics.
[239] Xinguo Jiang,et al. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[240] Kazunori Kataoka,et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling , 2007, Proceedings of the National Academy of Sciences.
[241] K. Ulbrich,et al. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[242] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[243] Wilson Mok,et al. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. , 2006, Cancer research.
[244] Hong-Zhuan Chen,et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[245] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[246] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[247] Rakesh K. Jain,et al. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.
[248] Crispin J. Miller,et al. Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance , 2004, Molecular and Cellular Biology.
[249] Rakesh K. Jain,et al. Pathology: Cancer cells compress intratumour vessels , 2004, Nature.
[250] Michel Vert,et al. Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.
[251] J. M. Harris,et al. Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.
[252] D. Hedley,et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. , 2001, Cancer research.
[253] M. Wientjes,et al. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. , 2001, The Journal of pharmacology and experimental therapeutics.
[254] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[255] D. Longo,et al. Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. , 1993, Cancer research.
[256] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[257] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.